Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...
Promising Late-Stage Drugs Signal A New Treatment Era Delveinsight. The generalized myasthenia gravis treatment pipeline ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Sedona-based Alternative to Meds Center highlights Glyphosate exposure, neurological health concerns, and more used in ...
Novartis announced final two-year results from the phase III APPLAUSE-IgAN study of Fabhalta (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a statistically significant, clinically ...
A 2026 informational report on Quietum Plus ear ringing relief positioning, auditory nerve support ingredients, proprietary ...
The proposal to use ethanol for commercial cooking comes amid the ongoing US-imposed blockade of the Strait of Hormuz, which ...
Researcher have developed a "Shallow Brain" AI model that mimics the connections between the cortex and subcortical regions, ...
Instead, a mental health startup shut down and open-sourced its tech.
5don MSN
New research on cellular redox reactions sheds light on the path of neurodegenerative diseases
The mechanics of the onset of cancer or neurodegenerative disorders like Alzheimer's disease or ALS remain a mystery.
GLP-1 medications may not always work for weight loss. New research suggests that around 10% of people carry genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results